Compounds > gadolinium
Page last updated: 2024-08-22

gadolinium and Diffuse Myofascial Pain Syndrome

gadolinium has been researched along with Diffuse Myofascial Pain Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lattanzio, SM1
Collidge, TA; Mark, PB; Thomson, PC; Traynor, JP1

Other Studies

2 other study(ies) available for gadolinium and Diffuse Myofascial Pain Syndrome

ArticleYear
The gadolinium hypothesis for fibromyalgia and unexplained widespread chronic pain.
    Medical hypotheses, 2019, Volume: 129

    Topics: Chronic Pain; Contrast Media; Cytokines; Fibromyalgia; Gadolinium; Humans; Ligands; Magnetic Resonance Imaging; Models, Theoretical; Neurotransmitter Agents; Patient Safety; Phenotype; Tumor Necrosis Factor-alpha

2019
Gadolinium contrast may be risky in kidney disease.
    BMJ (Clinical research ed.), 2007, Jun-30, Volume: 334, Issue:7608

    Topics: Contrast Media; Fibromyalgia; Gadolinium; Gadolinium DTPA; Humans; Kidney Diseases; Magnetic Resonance Angiography; Organometallic Compounds; Peripheral Vascular Diseases; Risk Factors

2007